Mediators of Inflammation

Mediators of Inflammation / 2016 / Article
Special Issue

Herbal Medicines for Inflammatory Diseases 2016

View this Special Issue

Research Article | Open Access

Volume 2016 |Article ID 3472608 | 15 pages | https://doi.org/10.1155/2016/3472608

Regulatory T Cell Induced by Poria cocos Bark Exert Therapeutic Effects in Murine Models of Atopic Dermatitis and Food Allergy

Academic Editor: Kyung H. Kim
Received18 Mar 2016
Revised09 May 2016
Accepted10 May 2016
Published29 Jun 2016

Abstract

The prevalence of allergic disorders including atopic dermatitis (AD) and food allergy (FA) has increased dramatically in pediatric populations, but there is no effective drug available for their management. Therefore, trials are required for the development of safe therapeutic agents such as herbal medicines. We determined whether orally administered Poria cocos bark (PCB) extract could exert immunosuppressive effects on allergic and inflammatory symptoms of AD and FA. For both AD, which was induced using house dust mite extract, and FA, which was induced by exposure to ovalbumin, model mice were orally treated with PCB extract for 62 days and 18 days, respectively. We also investigated the inductive effect of PCB extract on the generation and maintenance of Foxp3+CD4+ regulatory T cells (Tregs). The symptoms of AD and FA were ameliorated by the administration of PCB extract. Furthermore, PCB extract inhibited the Th2-related cytokines and increased the population of Foxp3+CD4+ Tregs in both AD and FA models. In ex vivo experiments, PCB extract promoted the functional differentiation of Foxp3+CD4+ Tregs, which is dependent on aryl hydrocarbon receptor activation. Thus, PCB extract has potential as an oral immune suppressor for the treatment of AD and FA through the generation of Tregs.

1. Introduction

Hypersensitivity diseases called allergic disorders result from the breakdown of natural tolerance, and their prevalence has increased worldwide. In particular, the incidence of atopic dermatitis (AD) and food allergy (FA) is increasing and they have been estimated to affect 10–20% and 5-6% of the pediatric population, respectively [1, 2].

AD is a chronic and allergic inflammatory skin disease [3] caused by both genetic and environmental factors [2]. In general, AD develops owing to sensitization of allergens such as food and house dust mite (HDM), and then abnormal patterns in the immune system contribute to the pathogenesis and development of AD [4]. In particular, T-helper type 2- (Th2-) dominant immune responses play key roles in AD. The number of various immune cells such as T lymphocytes, macrophages, eosinophils, and mast cells increases in AD and these cells infiltrate to form skin lesions. Therefore, these cells could be targeted to treat or prevent AD [5, 6].

FA is a hypersensitivity disorder caused by substances derived from foods and develops when the immune system reacts to food allergens after ingestion. Food allergens such as ovalbumin (OVA) and ovomucoid from eggs, caseins and beta-lactoglobulin from milk, peanut agglutinin from peanuts, and tropomyosins from shrimp are known [7]. Mild allergic reactions are common, causing symptoms such as diarrhea, hypotension, pruritus, and vomiting [8]. However, in severe cases, lethal anaphylactic shock can occur [9].

Regulatory T (Treg) cells and Forkhead box P3- (Foxp3-) expressing CD4+ T cells are important for the functions of the immune system. Since functional Foxp3+CD4+ T cells have immune suppressive activities, they are able to attenuate hyperimmune responses and the inflammatory, allergic, and autoimmune disorders due to these responses [1012]. Therefore, the induction of Foxp3 expression in these diseases may contribute to the induction of immune tolerance by generation of regulatory T cells [13] and suppress the symptoms of HDM-induced AD and OVA-induced FA.

The generation of Foxp3+ Tregs is driven by transforming growth factor-β (TGF-β) and interleukin-2 (IL-2) [14, 15]. Recent studies concluded that Treg generation is promoted by ligand-dependent activity and the expression of aryl hydrocarbon receptor (AhR), which is recruited to the Foxp3 promoter [16]. Natural AhR ligands can be isolated or synthesized from dietary compounds including curcumin, indirubin, or indole-3-carbinol (I3C), as well as 2,3,7,8-tetrachlorodibenzo-p-dioxin [1719]. The finding that natural ligands affect the induction of Foxp3+ Tregs via AhR activation is receiving increased attention [20, 21]. Therefore, these dietary AhR ligands might influence the onset of AD and FA.

Poria cocos is an edible basidiomycete that grows on pine tree roots; it is widely used as a traditional medicine in East Asia. The P. cocos extract has beneficial effects on inflammation and cancer [22]. Recent studies have focused on the beneficial effects of P. cocos derivatives on immune function [2325]. In particular, the P. cocos bark (PCB) extracts include triterpenoid compounds or/and ergosterol, which is used to treat inflammatory diseases including rheumatoid arthritis and systemic lupus erythematosus and symptoms associated with ulcerative colitis [26, 27]. However, the scientific evidence for the antiallergic effects of PCB extract is not clear.

The aim of this study was to determine whether PCB extract exerts an effect on the generation and maintenance of Foxp3+CD4+ Tregs. Furthermore, we investigated whether orally administered PCB extracts could improve allergic symptoms in murine models of HDM-induced AD and OVA-induced FA.

2. Materials and Methods

2.1. Sample Preparation

The PCB extract used in this study was from the Plant Extract Bank of Korea (Plant Diversity Research Center of the 21st Century Frontier Research Program). Voucher specimens were deposited at the herbarium of the Plant Extract Bank of Korea (Daejeon, Korea). Ethyl alcohol (EtOH; 95%) dried extracts were dissolved in saline (Sigma-Aldrich, St. Louis, MO) and dimethylsulfoxide (DMSO) before use. Endotoxin level in PCB extract using Pyrogent Plus assay kit (Lonza, Hopkinton, Massachusetts) was found to be below 0.06 EU/mL, which is the limit of sensitivity for this kit.

2.2. Animal Experiments

Four-week-old female BALB/c mice (18–20 g) were purchased from OrientBio Inc. (Kyeonggi, Korea) and housed at °C with a 12 h light/dark cycle and free access to food and water. This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health with special attention to minimizing animal pain. The study protocol was approved by the Animal Care and Use Committee of Korea Food Research Institute (Approval Number: KFRI-M-14018). No animals were sacrificed or died as a result of the experiment before day 35. Six-week-old female Foxp3-GFP C57BL/6 mice were previously described [28]. These mice were housed at °C with a 12 h light/dark cycle and free access to food and water. All experimental procedures were performed in compliance with the guidelines set by the University Animal Care and Use Committee at Seoul National University with special attention to minimizing animal pain. The study protocol was approved by the Seoul National University Institutional Animal Care and Use Committee (Approval Number: SNU-130807-4-1).

2.3. Cell Purification and Sorting

Naïve CD4+ T cells from BALB/c mice were isolated using a magnetic-activated cell sorting (MACS) CD4+CD62L+ T cell isolation kit (Miltenyi Biotec, Bergisch-Gladbach, Germany) following the manufacturer’s instructions. T cell-depleted cells, as antigen-presenting cells (APCs), were prepared from the spleen cells of BALB/c mice and mLN cells by negative selection using MACS. The purity of isolated cells was confirmed using FACS. Foxp3+CD4+ T cells were sorted from Foxp3eGFP to >99% purity using FACS Aria III (BD Biosciences) with anti-CD4, anti-CD45RB, and anti-CD25 antibodies (eBioscience). On day 3, the Treg population was isolated based on CD4 and Foxp3-eGFP expression using FACS.

2.4. Functional Differentiation of Naïve CD4+ T Cells

Naïve BALB/c CD4+ T cells (1 × 106 cells/well) were cultured in 96-well plates in the presence of 0–100 mg/mL PCB extract in 0.1% DMSO. T cell receptor (TCR) stimulation was performed using 10 μg/mL plate-bound anti-CD3 (BioLegend, San Diego, CA, 17A2) and 2 μg/mL soluble anti-CD28 (BioLegend, San Diego, CA, 37.51) antibodies. To analyze the CFSE+ population that was converted by Foxp3+CD4+ Treg, CD4+CD62L+ T cells labeled with 5 μM CFSE (Life Technologies, Australia) were cocultured with CD4+ cells that had been precultured in the presence or absence of PCB extract and/or TCR stimulation for 3 days. The CFSE+ population was then analyzed using FACS.

2.5. Induction of AD by Administration of HDM Extract in the Ear

The mice were divided into naïve (), sham (), PCB (), and dexamethasone () groups. To induce AD, the surfaces of both ear lobes of the mice were stripped using surgical tape (Shinshin Pharm., Korea). After stripping, 20 μL of 1% 2,4-dinitrochlorobenzene (DNCB) (Sigma-Aldrich, St. Louis, MO, USA) dissolved in acetone/olive oil solution (acetone : olive oil  =  1 : 3) was painted on each ear lobe. After 2 days, 20 μL of HDM extract (10 mg/mL, Dermatophagoides farinae, GREER Source Materials, Lenoir, NC, USA) dissolved in phosphate-buffered saline (PBS) was reapplied on each ear lobe. Challenges with DNCB and HDM extract were repeated once a week alternatively until 6 weeks; the naïve group was challenged with only tape stripping and PBS. PCB extract (25 mg/kg) was administered orally daily for 3 weeks before AD was induced by HDM and DNCB (Figure 1(a)). Clinical score was calculated using modified criteria [29]. Briefly, each ear region was assessed separately for erythema/edema, scaling/dryness, and excoriation/hemorrhage, and the average degree of severity in each ear region was assigned a score of 0, 1, 2, or 3, which indicated none, mild, moderate, and severe, respectively.

2.6. Analysis of Histological Changes in the Ear

Ear lesions of each group were fixed with 10% formalin solution and embedded in paraffin. They were then cut into 6 μm thick sections and stained with hematoxylin (Sigma-Aldrich, St. Louis, MO, USA) and eosin (Sigma-Aldrich, St. Louis, MO, USA) solution (H&E). H&E staining was performed according to standard procedures (IHC World, Online Information Center for Histochemistry; http://www.ihcworld.com/). All histologic analyses were performed by a professional pathologist at the College of Veterinary Medicine, Seoul National University. Analysis of stained sections was performed using a microscope at 100x and 200x magnification.

2.7. Isolation and Analysis of Infiltrated Cells in the Ears

Ear tissues were removed and placed in 1.0 mmol/L EDTA in RPMI 1640 medium. The ear tissues and solution were stirred in Erlenmeyer flasks for 20 min at room temperature. After stirring, the ear tissues were minced with experimental scissors and were rinsed with serum-free RPMI 1640 medium. The ear tissues were then incubated in 0.5 mg/mL collagenase type 1 (Sigma-Aldrich, St. Louis, MO, USA) in RPMI 1640 medium with slow rotation (130 rpm). After incubation, the solution containing ear cells was rinsed with cold PBS and passed through a 70 mm cell strainer. The filtered solution was centrifuged at 1300 rpm for 5 min. Cells were gathered and suspended in HBSS containing 10% FBS, 10% sodium azide, and 8% sodium bicarbonate. Infiltrated cells in ears were confirmed by flow cytometry. Surface molecules were stained with anti-CD4 (FITC), anti-CD8 (APC/Cy7), anti-CD11c (PE), anti-CD11b (APC), and anti-CD45R (PerCP/Cy5.5) (all from eBioscience, San Diego, CA, USA) for 30 min. Flow cytometry analysis was performed using BD Canto II instrument (BD Biosciences, San Diego, CA, USA).

2.8. Induction of the Anaphylactic Response by the Oral Administration of OVA

Mice were divided into naïve (), sham (), PCB (), and dexamethasone () groups. To induce an allergic response, mice were sensitized with 20 μg OVA in 2 mg/mL Imject Alum (Pierce, Rockford, IL) by intraperitoneal (i.p.) injection on day 0. Mice were then orally challenged with 50 mg OVA in saline every 3 days from day 17 for a total of six times. PCB extract (25 mg/kg) was administered orally daily from day 17 to 34 (Figure 1(b)). Diarrhea, anaphylaxis, and rectal temperature were measured as food allergy symptoms. To define diarrhea, the state of murine feces was observed and evaluated by visually monitoring once every 15 minutes for 1 hour after OVA challenge.

The criteria of diarrhea are the formlessness of stool and liquid shape (>80% water). The frequency, amount, and volume of stool were not used as an index showing a state of diarrhea. Temperature changes were measured with a rectal temperature probe (RET3) coupled to the Physitemp Thermalert Model TH-5 (Physitemp, Clifton, NJ). After OVA challenge, temperatures were measured every 15 minutes. Symptom scores were determined according to previously detailed criteria [30].

2.9. Measurement of Cytokine Levels Using ELISA

The mesenteric lymph node (mLN) from each mouse was removed aseptically. The mLNs were then homogenized into single-celled suspensions; 5 × 106 cells/mL were added to RPMI medium, and cell viability was determined using trypan blue dye exclusion. Cells (200 μL/well) were cultured in the presence or absence of OVA (100 μg/mL) at 37°C for 72 h in a humidified incubator with 5% CO2 and 95% air. Cytokine assay kits (interferon γ [IFN-γ], IL-4, IL-5, IL-10, and IL-13, BD Pharmingen, San Diego, CA, and IL-17 and TGF-β, R&D Systems, Minneapolis, MN) were used to quantify cytokines following the manufacturer’s instructions. The absorbance at 450 nm was measured using a microplate reader (Molecular Devices, Sunnyvale, CA).

2.10. Immunofluorescence Staining

To stain Foxp3 intracellularly, cells were washed in fluorescence-activated cell sorting (FACS) buffer (1% fetal calf serum and 0.1% NaN3 in PBS) and incubated with anti-CD16/32 antibody 2.4G2 for 5 min at 4°C to block Fc receptors (clone: 2.4G2) (BD Pharmingen, San Diego, CA). Surface CD4 molecules were stained with Phycoerythrin- (PE-) labeled anti-CD4 (clone: H129.19) (BioLegend, San Diego, CA) for 30 min at 4°C. The cells were then fixed and permeabilized using Foxp3 fixation/permeabilization concentrate and diluent (BD Biosciences, San Jose, CA) for 1 h at 4°C. After Fc receptors were blocked for 15 min, cells were stained using peridinin chlorophyll-a protein-Cy5.5- (PerCP-Cy5.5-) labeled anti-Foxp3 (clone: FJK-16s) (eBioscience, San Diego, CA) in FACS buffer at 4°C for 30 min. Data were acquired by flow cytometry using BD FACSCanto II (BD Biosciences) and analyzed using FlowJo software (Treestar, San Carlos, CA).

2.11. Quantitative Real-Time Reverse Transcription-Polymerase Chain Reaction (RT-PCR)

RNA from spleens and mLNs was extracted and purified using the RNeasy Mini Kit (Qiagen, Hilden, Germany), and cDNA was synthesized using the QuantiTect Reverse Transcription Kit (Qiagen). RT-PCR was performed in a Rotor-Gene Q 2plex System (Qiagen) as follows: 10 min at 95°C, followed by 45 cycles of 30 s at 95°C and 30 s at 62°C. The Assays-on-Demand kit (Qiagen) was used to analyze the expression of HPRT (housekeeping gene), Foxp3, CTLA-4, AhR, and Granzyme B (GranB). The sequences of the primers used are provided in Table 1. HPRT was used to normalize mRNA expression. The data are shown as relative delta delta CT (ΔΔCT); the fold-induction of each gene was calculated as follows: ΔThreshold cycle (ΔCt) = (Ct of target mRNA) − (Ct of HPRT); ΔΔCt = (ΔCt of mRNA in target gene) − (ΔCt of mRNA in control gene); fold-induction = .


GenePrimerSequence

Hypoxanthine-guanine phosphoribosyl transferaseSense5′-CTGGTGAAAAGGACCTCTCG-3′
Antisense5′-TGAAGTACTCATTATAGTCAAGGGCA-3′

Forkhead box P3Sense5′-CAGCTGCCTACAGTGCCCCTAG-3′
Antisense5′-CATTTGCCAGCAGTGGGTAG-3′

Cytotoxic T-lymphocyte antigen 4Sense5′-AGA ACC ATG CCC GGA TTC TG-3′
Antisense5′-CAT CTT GCT CAA AGA AAC AGC AG-3′

Granzyme B Sense5′-CTC CTA AAG CTG AAG AGT AAG G-3′
Antisense5′-TTT AAA GTA GGA CTC ACA CTC CC-3′

Aryl hydrocarbon receptor Sense5′-TGCACAAGGAGTGGACGA-3′
Antisense5′-AGGAAGCTGGTCTGGGGTAT-3′

2.12. Statistical Analysis

Data are presented as mean ± standard deviation (SD) of triplicate measurements. Differences between experimental data were analyzed using ANOVA followed by F-protected Fisher’s least significant difference test, unpaired -test, or one-way repeated measures of ANOVA followed by Tukey’s or Dunnett’s post hoc test. ND equals not detected. Statistical differences were presented as , , and .

3. Results

3.1. Effects of PCB Extract on the Symptoms of HDM-Induced AD

In this study, we investigated the antiallergic effects of PCB extract in a mouse model of AD. The mice were orally administered with PCB extract at a dose of 25 mg/kg daily for 9 weeks. Ear thickness was evaluated on the day after the HDM challenge every week for 6 weeks. We found that PCB extract ameliorated ear thickness and epidermis thickness in models of HDM-induced AD (Figures 2(a)2(c)). Furthermore, the clinical scores for criteria including erythema/edema, scaling/dryness, and excoriation/hemorrhage significantly reduced to points in the PCB extract group compared to points in the sham group (Figure 2(d)). We also examined the immune cells that infiltrated the ear in the AD models. The results indicated that, in ears of animals of the sham group, HDM treatment induced the infiltration of various immune cells such as CD4+ (T-helper cells), CD8+ (cytotoxic T cells), B220+ (B cells), CD11b+ (macrophages), and CD11c+ (dendritic cells) cells. However, the administration of PCB extract significantly reduced the infiltration of all these immune cells in the ears of animals in the PCB group (Figure 3(a)).

We next investigated how the PCB extract affected the Th2-related immune response in lymph nodes such as the spleen, mesenteric lymph node (mLN), and draining lymph node (dLN). The HDM-induced Th2-mediated immune responses were suppressed by the administration of PCB extract in each lymph node. In particular, HDM challenge strongly induced IL-4 production in the dLN, which was decreased by treatment with the PCB extract (Figure 3(b)). Meanwhile, administration of PCB extract enhanced the production of IL-10, which is a known anti-inflammatory cytokine in dLN. Since the PCB extract suppressed IL-4 production, enhanced IL-10 production in the lymph nodes, and decreased the population of immune cells in the inflammatory region, we investigated the induction of Tregs by analyzing the population of CD4+Foxp3+ T cells. We found that the administration of PCB extract promoted the expression of Foxp3 on CD4+ T cells in the dLN isolated from AD models (Figure 3(d)). These results demonstrated that the administration of PCB extract was able to attenuate the symptoms of AD by inducing Tregs in a mouse model of AD.

3.2. Effects of PCB Extract on the Response to OVA-Induced Food Allergies

In this study, we investigated antiallergic effects of PCB extract in a mouse model of food allergy. We treated mice with PCB extract (25 mg/kg) on a daily basis by oral gavage. Food allergy symptoms were induced by oral challenges with OVA, and the following symptoms were evaluated. Any of the groups did not reach death by anaphylactic shock. Severe food allergy symptoms were observed in the sham group (scores: diarrhea, 3; anaphylactic response, 2.7) after the sixth oral challenge on day 34. On the contrary, OVA-induced diarrhea symptoms and the anaphylactic response were noticeably suppressed to 2 points and 1.3 in the PCB-treated group, respectively (Figures 4(a)4(d)). Moreover, rectal temperature in the sham group decreased by −7.15°C compared with naïve mice. However, PCB extract treatment significantly ameliorated the OVA-induced decrease in rectal temperature to −2.65°C compared with control (Figure 4(e)). Although Dex completely blocked the food allergy symptoms, these mice group showed significant side effects of glucocorticoid, including serious size loss of splenocyte and mLN, and reduction of body weight by more than 7%. In contrast, PCB-treated group showed increase of body weights by more than 7% and no significant side effects (Figure 4(f)). This suggests that the oral administration of PCB extract attenuated food allergies by inhibiting diarrhea and the anaphylactic response without side effects.

To prove the mechanism of how PCB controls food allergies, we next assessed cytokine expression in mLNs isolated from mice with OVA-induced food allergies. The Th2-related cytokines IL-4, IL-5, and IL-13 were increased in mLNs from food allergy-induced mice. However, this increase was inhibited significantly by treatment with PCB extract (Figures 5(a)5(c)). In contrast, PCB treatment increased significantly in the TGF-β production which modulates the differentiation of T cells to Tregs (Figure 5(d)). Moreover, the PCB extract significantly increased the Foxp3+CD4+ Treg population in comparison with sham group (Figure 5(e)). This suggests that PCB extract regulates the abnormal Th2 dominance after allergic responses to food by increasing Tregs.

3.3. PCB Extracts Induced the Generation and Maintenance of Functional Foxp3+CD4+ Tregs

To determine how PCB extract increased Foxp3+CD4+ Tregs specifically, CD4+CD62L+ naïve T cells were cotreated with TCR stimulation using anti-CD3/-CD28 mAbs or anti-CD3/APCs in the presence of PCB. The Foxp3+CD4+ T cell population in mLNs and splenocytes was then measured using FACS. Compared with control, PCB extract significantly increased the Foxp3+CD4+ Treg population with or without APC (Figure 6(a)). The PCB extract significantly increased the Foxp3+CD4+ Treg population in a dose-dependent manner (Figure 6(b)). We next examined whether PCB-induced Foxp3+CD4+ Tregs could suppress naïve CD4+ T cell proliferation. CFSE-labeled CD4+CD62L+ naïve T cells were cocultured with T cells, which had been precultured with PCB extract for 3 days, in the presence or absence of TCR stimulation for 3 days. CD4+ T cell proliferation was then analyzed by measuring the CFSE signal using FACS. CD4+CD62L+ T cells cocultured with PCB-treated CD4+ cells showed significantly reduced proliferation compared with control (59.6 versus 75%), presumably because of their increased Foxp3+ Treg population (Figure 6(c)).

To assess the effect of PCB extract on the maintenance of Foxp3 expression in Tregs, we isolated Foxp3-GFP by sorting CD45.2+ nTregs from the thymus of C57BL/6 mice. The stability of Foxp3+ Tregs in control group decreased significantly by 63.43% from 99% after 3 days. In contrast, the expression of Foxp3 in PCB-treated Tregs remained 74.91% (Figures 6(d) and 6(e)). These results indicated that PCB possesses activity that might directly generate and stabilize functional Foxp3+CD4+ Tregs.

3.4. PCB Extract Suppressed Cytokine Production in Effector T Cells

We investigated whether the increased expression of CD4+Foxp3+ Tregs affected effector T cell function. CD4+CD62L+ T cells were isolated from the spleen and mLNs of BALB/c mice and were treated with anti-CD3 and anti-CD28 antibodies for 72 h. The levels of Th1 (IFN-γ), Th2 (IL-4), Th17 (IL-17), and Treg (TGF-β) cytokines in culture supernatants were then measured using ELISA. IFN-γ, IL-4, and IL-17 levels decreased in the PCB-treated compared with the TCR stimulated group, but TGF-β levels were increased in PCB-treated cells (Figures 7(a)7(d)).

To further confirm the effect of PCB extract on Treg-related gene expression, CD4+CD62L+ T cells isolated from mouse spleens and mLNs were treated with anti-CD3 and anti-CD28 antibodies for 24 hr. The mRNA expression of Treg-associated genes was then measured (Figure 7(e)). PCB-treated inducible Foxp3+CD4+ T cells upregulated CTLA-4, GranB, and TGF-β expression compared with control. The expression of AhR also increased dramatically after treatment with PCB extract. This suggests that PCB extract could exert immunosuppressive effects on effector T cells by inducing functional Foxp3+CD4+ Tregs.

3.5. PCB Extract Directly Affects Naïve CD4+ T Cells to Induce Tregs via AhR Activation

AhR activation suppresses Th2-type cells and antibody responses and induces Foxp3+ Tregs [16, 31]. We measured whether the PCB-induced expression of Foxp3 in naïve CD4+ T cells required AhR activation. Naïve CD4+CD62L+ T cells were cultured with resveratrol, an AhR antagonist [32], TCR stimulation, and PCB extract. Resveratrol decreased the PCB-induced Foxp3+CD4+ Treg population in a dose-dependent manner (Figure 8). This suggests that the induction of functional Foxp3+CD4+ Tregs by PCB extract required AhR activation.

4. Discussion

In this study, we focused on the antiallergic role of Tregs, which were induced by PCB extract, and whether these Tregs were associated with immune tolerance in AD and FA. This study demonstrated that the oral administration of PCB extract suppressed allergic symptoms without side effects and induced Foxp3+CD4+ Tregs. Furthermore, our data showed that PCB extract promoted the generation and maintenance of functional Foxp3+CD4+ Tregs in an AhR-dependent manner.

We confirmed that PCB extract effectively suppressed IL-4 production, which is the main Th2-mediated cytokine, and is a potent oral immune regulator of in HDM-induced experimental AD. We suggest that the underlying mechanism is induction of Tregs because the oral administration of PCB extract induced both CD4+Foxp3+ T cells and IL-10 production. IL-10-producing CD4+ T cells are well known as type 1 T regulatory (Tr1) cells, and an increase in their population could ameliorate AD [33, 34]. However, it was known that other immune cells such as macrophages, B cells, and dendritic cells could also promote IL-10 production with Treg or Tr1. IL-10-producing cells called type 2 macrophages, Breg, and tolerogenic DC also could suppress Th2-related immune responses in allergic disorders such as AD [3537]. The main population of IL-10-producing cells in HDM-induced AD may be revealed through further studies.

Increase in Foxp3+CD4+ Tregs has been linked to inhibition of FAs initiated by Th2-related cytokines such as IL-4, IL-5, and IL-13 [3840]. In this study, PCB extract administration significantly promoted oral tolerance via the generation of Foxp3+ Tregs and suppressed OVA-induced Th2-dominant immune responses in FA. Previous studies have demonstrated that the induction of Tregs could alleviate symptoms of food allergy, despite the relatively small proportion in immune cells [41]. Tregs inhibit the uncontrolled activation and expansion of T cells [15]. They directly suppress the activation and expansion of allergen-specific Th2 cells during allergic reactions [15, 42]. Many studies have reported the role played by TGF-β in mechanisms regulating the induction of tolerance at the gastrointestinal tract [43, 44]. TGF-β can efficiently convert naïve T cells into Tregs. TGF-β promote the nuclear translocalization of phosphorylated Smad3 which contributes to Foxp3 initiation [45], a Treg-specific transcription factor. Our data also showed that oral administration of PCB extract increased TGF-β production and Foxp3 expression in mLN of the OVA-induced pathogenic mice. Moreover, PCB extracts stabilized the expression of inducible Foxp3. We therefore suppose that oral tolerance by administration of PCB may improve allergic disorders such as FA via the stable induction of TGF-β-dominated Foxp3 expression.

AhR plays an important role in T cell differentiation. Curcumin, a dietary AhR compound found in turmeric, attenuates inflammation in asthma and systemic lupus erythematosus by regulating the induction of Tregs [19, 46, 47]. In addition, I3C and indirubin increase the number of CD4+CD25+ Tregs and suppress chronic inflammatory diseases and/or autoimmunity in vivo [20]. In this study, PCB extract significantly increased AhR expression. Moreover, no increase in Foxp3 expression was found in the presence of the AhR antagonist resveratrol. This suggests that the immunosuppressive effects of PCB extract are mediated via AhR and that AhR expression and activation are essential for PCB-mediated Foxp3+ Treg generation. Some chemical constituents of PCB have been reported to be AhR agonists. For example, ergosterol regulated human CYP enzymes via AhR activation [48, 49] and hydrophobic triterpenes have a high affinity for AhR and induce its activation [26, 27, 50]. In this study, we found that CD4+Foxp3+ Tregs were efficiently generated by the hexane fraction of PCB containing ergosterol and triterpenes (data not shown). Consequently, it could be speculated that the ergosterol and triterpenes of PCB can induce Tregs. However, there remains a need to explore the putative compound(s) responsible for Foxp3 expression in naïve CD4+CD62L+ T cells in the hexane fraction of PCB.

In conclusion, PCB extracts exerted potent immunosuppressive effects by potentiating the generation and maintenance of functional Foxp3+CD4+ Tregs in an AhR-dependent manner. Moreover, PCB-induced Foxp3+CD4+ Tregs effectively suppressed the symptoms of AD and FAs. Therefore, PCB extracts have potential as orally active immune suppressors for the treatment of hypersensitive immune responses disorders such as AD and FA.

Abbreviations

AD:Atopic dermatitis
APCs:Antigen-presenting cells
Dex:Dexamethasone
DfE: Dermatophagoides farinae extracts
dLN:Draining lymph node
DNCB:Dinitrochlorobenzene
Foxp3:Forkhead box P3
H&E:Hematoxylin and eosin
IFN:Interferon
Ig:Immunoglobulin
IL:Interleukin
iTreg:Inducible Treg
mLN:Mesenteric lymph node
OVA:Ovalbumin
PCB: Poria cocos
RORγT:Retinoic acid-related orphan receptor γT
TCR:T cell receptor
Teff cells:Effector T cells
TGF-β:Transforming growth factor-β
Th:T-helper
Th17 cells:IL-17-producing Th cells
Tregs:Regulatory T cells.

Competing Interests

The authors have declared no conflict of interests.

Authors’ Contributions

Min-Jung Bae and Hye-Jeong See contributed equally to this work.

Acknowledgments

This study was supported by research grants (E0121304-05) from the Korea Food Research Institute (KFRI).

References

  1. C. Venter, B. Pereira, K. Voigt et al., “Prevalence and cumulative incidence of food hypersensitivity in the first 3 years of life,” Allergy, vol. 63, no. 3, pp. 354–359, 2008. View at: Publisher Site | Google Scholar
  2. D. Y. M. Leung, M. Boguniewicz, M. D. Howell, I. Nomura, and Q. A. Hamid, “New insights into atopic dermatitis,” Journal of Clinical Investigation, vol. 113, no. 5, pp. 651–657, 2004. View at: Publisher Site | Google Scholar
  3. D. Y. Leung and T. Bieber, “Atopic dermatitis,” The Lancet, vol. 361, no. 9352, pp. 151–160, 2003. View at: Publisher Site | Google Scholar
  4. J. M. Spergel, “From atopic dermatitis to asthma: the atopic march,” Annals of Allergy, Asthma and Immunology, vol. 105, no. 2, pp. 99–106, 2010. View at: Publisher Site | Google Scholar
  5. N. Novak, “New insights into the mechanism and management of allergic diseases: atopic dermatitis,” Allergy, vol. 64, no. 2, pp. 265–275, 2009. View at: Publisher Site | Google Scholar
  6. S. Bonness and T. Bieber, “Molecular basis of atopic dermatitis,” Current Opinion in Allergy and Clinical Immunology, vol. 7, no. 5, pp. 382–386, 2007. View at: Publisher Site | Google Scholar
  7. S. H. Sicherer and H. A. Sampson, “Food allergy,” The Journal of Allergy and Clinical Immunology, vol. 125, no. 2, supplement 2, pp. S116–S125, 2010. View at: Publisher Site | Google Scholar
  8. M. Ben-Shoshan and A. E. Clarke, “Anaphylaxis: past, present and future,” Allergy, vol. 66, no. 1, pp. 1–14, 2011. View at: Publisher Site | Google Scholar
  9. J. J. Koplin, P. E. Martin, and K. J. Allen, “An update on epidemiology of anaphylaxis in children and adults,” Current Opinion in Allergy and Clinical Immunology, vol. 11, no. 5, pp. 492–496, 2011. View at: Publisher Site | Google Scholar
  10. T. M. Brusko, A. L. Putnam, and J. A. Bluestone, “Human regulatory T cells: role in autoimmune disease and therapeutic opportunities,” Immunological Reviews, vol. 223, no. 1, pp. 371–390, 2008. View at: Publisher Site | Google Scholar
  11. C. Dejaco, C. Duftner, B. Grubeck-Loebenstein, and M. Schirmer, “Imbalance of regulatory T cells in human autoimmune diseases,” Immunology, vol. 117, no. 3, pp. 289–300, 2006. View at: Publisher Site | Google Scholar
  12. S. A. Long and J. H. Buckner, “CD4+FOXP3+ T regulatory cells in human autoimmunity: more than a numbers game,” Journal of Immunology, vol. 187, no. 5, pp. 2061–2066, 2011. View at: Publisher Site | Google Scholar
  13. M. Chehade and L. Mayer, “Oral tolerance and its relation to food hypersensitivities,” The Journal of Allergy and Clinical Immunology, vol. 115, no. 1, pp. 3–12, 2005. View at: Publisher Site | Google Scholar
  14. L. Gabryšová, J. R. Christensen, X. Wu, A. Kissenpfennig, B. Malissen, and A. O'Garra, “Integrated T-cell receptor and costimulatory signals determine TGF-β-dependent differentiation and maintenance of Foxp3+ regulatory T cells,” European Journal of Immunology, vol. 41, no. 5, pp. 1242–1248, 2011. View at: Publisher Site | Google Scholar
  15. S. Hori, T. Nomura, and S. Sakaguchi, “Control of regulatory T cell development by the transcription factor Foxp3,” Science, vol. 299, no. 5609, pp. 1057–1061, 2003. View at: Publisher Site | Google Scholar
  16. F. J. Quintana, A. S. Basso, A. H. Iglesias et al., “Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor,” Nature, vol. 453, no. 7191, pp. 65–71, 2008. View at: Publisher Site | Google Scholar
  17. J. Adachi, Y. Mori, S. Matsui et al., “Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine,” The Journal of Biological Chemistry, vol. 276, no. 34, pp. 31475–31478, 2001. View at: Publisher Site | Google Scholar
  18. M. Ociepa-Zawal, B. Rubiś, M. Łaciński, and W. H. Trzeciak, “The effect of indole-3-carbinol on the expression of CYP1A1, CYP1B1 and AhR genes and proliferation of MCF-7 cells,” Acta Biochimica Polonica, vol. 54, no. 1, pp. 113–117, 2007. View at: Google Scholar
  19. A. Goergens, M. Frericks, and C. Esser, “The arylhydrocarbon receptor is only marginally involved in the antileukemic effects of its ligand curcumin,” Anticancer Research, vol. 29, no. 11, pp. 4657–4664, 2009. View at: Google Scholar
  20. J. M. Benson and D. M. Shepherd, “Dietary ligands of the aryl hydrocarbon receptor induce anti-inflammatory and immunoregulatory effects on murine dendritic cells,” Toxicological Sciences, vol. 124, no. 2, pp. 327–338, 2011. View at: Publisher Site | Google Scholar
  21. A. L. Mellor, P. Chandler, B. Baban et al., “Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase,” International Immunology, vol. 16, no. 10, pp. 1391–1401, 2004. View at: Publisher Site | Google Scholar
  22. J.-L. Ríos, “Chemical constituents and pharmacological properties of poria cocos,” Planta Medica, vol. 77, no. 7, pp. 681–691, 2011. View at: Publisher Site | Google Scholar
  23. S. M. Fuchs, C. Heinemann, S. Schliemann-Willers, H. Härtl, J. W. Fluhr, and P. Elsner, “Assessment of anti-inflammatory activity of Poria cocos in sodium lauryl sulphate-induced irritant contact dermatitis,” Skin Research and Technology, vol. 12, no. 4, pp. 223–227, 2006. View at: Publisher Site | Google Scholar
  24. H.-H. Chang, C.-H. Yeh, and F. Sheu, “A novel immunomodulatory protein from Poria cocos induces Toll-like receptor 4-dependent activation within mouse peritoneal macrophages,” Journal of Agricultural and Food Chemistry, vol. 57, no. 14, pp. 6129–6139, 2009. View at: Publisher Site | Google Scholar
  25. Y.-T. Lu, Y.-C. Kuan, H.-H. Chang, and F. Sheu, “Molecular cloning of a Poria cocos protein that activates Th1 immune response and allays Th2 cytokine and IgE production in a murine atopic dermatitis model,” Journal of Agricultural and Food Chemistry, vol. 62, no. 13, pp. 2861–2871, 2014. View at: Publisher Site | Google Scholar
  26. T. Akihisa, Y. Nakamura, H. Tokuda et al., “Triterpene acids from Poria cocos and their anti-tumor-promoting effects,” Journal of Natural Products, vol. 70, no. 6, pp. 948–953, 2007. View at: Publisher Site | Google Scholar
  27. S. Ohno, “Roles of Kampo medicine in treating rheumatic diseases,” Journal of Traditional Medicines, vol. 24, no. 3, pp. 73–80, 2007. View at: Google Scholar
  28. I.-K. Kim, B.-S. Kim, C.-H. Koh et al., “Glucocorticoid-induced tumor necrosis factor receptor-related protein co-stimulation facilitates tumor regression by inducing IL-9-producing helper T cells,” Nature Medicine, vol. 21, no. 9, pp. 1010–1017, 2015. View at: Publisher Site | Google Scholar
  29. H.-K. Kwon, C.-G. Lee, J.-S. So et al., “Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 5, pp. 2159–2164, 2010. View at: Publisher Site | Google Scholar
  30. H. S. Shin, M.-J. Bae, S. Y. Jung, and D.-H. Shon, “Preventive effects of skullcap (Scutellaria baicalensis) extract in a mouse model of food allergy,” Journal of Ethnopharmacology, vol. 153, no. 3, pp. 667–673, 2014. View at: Publisher Site | Google Scholar
  31. V. J. Schulz, J. J. Smit, M. Bol-Schoenmakers, M. B. M. van Duursen, M. van den Berg, and R. H. H. Pieters, “Activation of the aryl hydrocarbon receptor reduces the number of precursor and effector T cells, but preserves thymic CD4+CD25+Foxp3+ regulatory T cells,” Toxicology Letters, vol. 215, no. 2, pp. 100–109, 2012. View at: Publisher Site | Google Scholar
  32. H. P. Ciolino, P. J. Daschner, and G. C. Yeh, “Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor,” Cancer Research, vol. 58, no. 24, pp. 5707–5712, 1998. View at: Google Scholar
  33. M. K. Levings, R. Bacchetta, U. Schulz, and M. G. Roncarolo, “The role of IL-10 and TGF-beta in the differentiation and effector function of T regulatory cells,” International archives of allergy and immunology, vol. 129, no. 4, pp. 263–276, 2002. View at: Publisher Site | Google Scholar
  34. N. Fyhrquist, S. Lehtimäki, K. Lahl et al., “Foxp3 + cells control Th2 responses in a murine model of atopic dermatitis,” Journal of Investigative Dermatology, vol. 132, no. 6, pp. 1672–1680, 2012. View at: Publisher Site | Google Scholar
  35. K. A. Haitz and N. Anandasabapathy, “Docosahexaenoic acid alleviates atopic dermatitis in mice by generating T regulatory cells and m2 macrophages,” The Journal of Investigative Dermatology, vol. 135, no. 6, pp. 1472–1474, 2015. View at: Publisher Site | Google Scholar
  36. J. Li, C. Shen, Y. Liu et al., “Impaired Function of CD5+CD19+CD1dhi B10 cells on IgE secretion in an atopic dermatitis-like mouse model,” PLoS ONE, vol. 10, no. 8, Article ID e0132173, 2015. View at: Publisher Site | Google Scholar
  37. T. Volz, Y. Skabytska, E. Guenova et al., “Nonpathogenic bacteria alleviating atopic dermatitis inflammation induce IL-10-producing dendritic cells and regulatory Tr1 cells,” Journal of Investigative Dermatology, vol. 134, no. 1, pp. 96–104, 2014. View at: Publisher Site | Google Scholar
  38. C. M. Cabrera and J. M. Urra, “Food allergy and the oral immunotherapy approach,” Archivum Immunologiae et Therapiae Experimentalis, vol. 63, no. 1, pp. 31–39, 2015. View at: Publisher Site | Google Scholar
  39. S. Cao, T. J. Feehley, and C. R. Nagler, “The role of commensal bacteria in the regulation of sensitization to food allergens,” FEBS Letters, vol. 588, no. 22, pp. 4258–4266, 2014. View at: Publisher Site | Google Scholar
  40. A. Syed, M. A. Garcia, S.-C. Lyu et al., “Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3),” The Journal of Allergy and Clinical Immunology, vol. 133, no. 2, pp. 500–510, 2014. View at: Publisher Site | Google Scholar
  41. M. R. Karlsson, J. Rugtveit, and P. Brandtzaeg, “Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy,” Journal of Experimental Medicine, vol. 199, no. 12, pp. 1679–1688, 2004. View at: Publisher Site | Google Scholar
  42. O. Palomares, G. Yaman, A. K. Azkur, T. Akkoc, M. Akdis, and C. A. Akdis, “Role of Treg in immune regulation of allergic diseases,” European Journal of Immunology, vol. 40, no. 5, pp. 1232–1240, 2010. View at: Publisher Site | Google Scholar
  43. D. Mucida, N. Kutchukhidze, A. Erazo, M. Russo, J. J. Lafaille, and M. A. Curotto de Lafaille, “Oral tolerance in the absence of naturally occurring Tregs,” Journal of Clinical Investigation, vol. 115, no. 7, pp. 1923–1933, 2005. View at: Publisher Site | Google Scholar
  44. Y. Belkaid and G. Oldenhove, “Tuning microenvironments: induction of regulatory T cells by dendritic cells,” Immunity, vol. 29, no. 3, pp. 362–371, 2008. View at: Publisher Site | Google Scholar
  45. S. M. Schlenner, B. Weigmann, Q. Ruan, Y. Chen, and H. von Boehmer, “Smad3 binding to the foxp3 enhancer is dispensable for the development of regulatory T cells with the exception of the gut,” Journal of Experimental Medicine, vol. 209, no. 9, pp. 1529–1535, 2012. View at: Publisher Site | Google Scholar
  46. C. Ma, Z. Ma, Q. Fu, and S. Ma, “Curcumin attenuates allergic airway inflammation by regulation of CD4+CD25+ regulatory T cells (Tregs)/Th17 balance in ovalbumin-sensitized mice,” Fitoterapia, vol. 87, no. 1, pp. 57–64, 2013. View at: Publisher Site | Google Scholar
  47. H. Lee, H. Kim, G. Lee, H.-S. Chung, and H. Bae, “Curcumin attenuates lupus nephritis upon interaction with regulatory T cells in New Zealand Black/White mice,” The British Journal of Nutrition, vol. 110, no. 1, pp. 69–76, 2013. View at: Publisher Site | Google Scholar
  48. S.-J. Yu and J. Tseng, “Fu-Ling, a Chinese herbal drug, modulates cytokine secretion by human peripheral blood monocytes,” International Journal of Immunopharmacology, vol. 18, no. 1, pp. 37–44, 1996. View at: Publisher Site | Google Scholar
  49. T. Sanderson and M. van den Berg, “Interactions of xenobiotics with the steroid hormone biosynthesis pathway,” Pure and Applied Chemistry, vol. 75, no. 11-12, pp. 1957–1971, 2003. View at: Google Scholar
  50. D. Sliva, J. Loganathan, J. Jiang et al., “Mushroom ganoderma lucidum prevents colitis-associated carcinogenesis in mice,” PLoS ONE, vol. 7, no. 10, Article ID e47873, 2012. View at: Publisher Site | Google Scholar

Copyright © 2016 Min-Jung Bae et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

1338 Views | 570 Downloads | 5 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.